Figure 5.
Pragmatic use of sodium–glucose co-transporter inhibitors. AHA: Anti-hyperglycemic agents, MOA: Mechanism of action, SGLT2i: Sodium–glucose co-transporter inhibitors, T2DM: Type-2 diabetes mellitus
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.